通过专为投资者打造的一站式数据看板，全面查看 Keros Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

228.57M

股息TTM

0.00

市盈率 TTM

-4.57

每股收益TTM

-2.53

营业收入

244.06M

净利润

-187.35M

净资产收益率

-16.79%

总资产收益率

-15.53%

Keros Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-91.84%-1.45

-133.00%-1.21

24.06%-0.87

87.28%-0.18

39.71%-0.76

402.94%3.66

14.61%-1.14

-5.97%-1.41

1.06%-1.25

4.27%-1.21

-22.90%-1.34

---1.33

---1.27

---1.26

---1.09

----

营业收入

-100.00%0.00

-99.83%367.00K

-87.34%385.00K

3575.77%14.26M

49002.70%18.17M

254413.25%211.25M

2027.27%3.04M

4750.00%388.00K

--37.00K

--83.00K

--143.00K

--8.00K

----

-100.00%0.00

--0.00

-100.00%0.00

----

--20.00M

--0.00

净利润

6.47%-28.71M

-115.97%-23.71M

49.03%-23.46M

86.25%-7.28M

32.17%-30.70M

444.32%148.45M

-14.37%-46.03M

-34.27%-52.96M

-20.67%-45.26M

-20.42%-43.11M

-35.42%-40.24M

-67.77%-39.44M

-37.55%-37.51M

-48.04%-35.80M

-328.21%-29.72M

-15.82%-23.51M

-74.54%-27.27M

-52.26%-24.19M

28.19%-6.94M

-68.64%-20.30M

利润率

----

-9292.51%-6459.95%

-302.76%-6093.77%

99.63%-51.04%

99.86%-168.96%

100.14%70.27%

94.62%-1513.02%

97.23%-13648.45%

---122316.22%

---51944.58%

---28141.96%

---493000.00%

----

毛利率

----

0.00%100.00%

--100.00%

----

资产负债率

----

--0.00%

----

利润表

营业收入

-100.00%0.00

-99.83%367.00K

-87.34%385.00K

3575.77%14.26M

49002.70%18.17M

254413.25%211.25M

2027.27%3.04M

4750.00%388.00K

--37.00K

--83.00K

--143.00K

--8.00K

----

-100.00%0.00

--0.00

-100.00%0.00

----

--20.00M

--0.00

营业利润

22.30%-30.94M

-117.02%-25.88M

45.04%-29.27M

73.77%-15.38M

21.06%-39.82M

413.59%152.04M

-14.64%-53.25M

-35.53%-58.66M

-22.02%-50.44M

-24.73%-48.48M

-45.35%-46.45M

-54.70%-43.28M

-34.53%-41.34M

-61.11%-38.87M

-556.80%-31.96M

-38.52%-27.98M

-97.72%-30.73M

-53.00%-24.13M

63.39%-4.87M

-69.04%-20.20M

净利润

6.47%-28.71M

-115.97%-23.71M

49.03%-23.46M

86.25%-7.28M

32.17%-30.70M

444.32%148.45M

-14.37%-46.03M

-34.27%-52.96M

-20.67%-45.26M

-20.42%-43.11M

-35.42%-40.24M

-67.77%-39.44M

-37.55%-37.51M

-48.04%-35.80M

-328.21%-29.72M

-15.82%-23.51M

-74.54%-27.27M

-52.26%-24.19M

28.19%-6.94M

-68.64%-20.30M

资产负债表

流动资产

-63.58%266.88M

-61.73%290.68M

-46.44%315.43M

30.30%719.31M

69.35%732.81M

64.00%759.51M

69.57%588.89M

81.33%552.05M

29.44%432.71M

27.86%463.13M

21.53%347.29M

23.82%304.44M

50.35%334.31M

56.66%362.22M

13.65%285.77M

8.76%245.88M

-7.90%222.36M

-9.67%231.22M

-6.08%251.44M

65.72%226.07M

流动负债总额

-64.98%12.15M

-67.36%12.85M

-25.63%20.41M

-16.94%24.09M

63.37%34.71M

110.38%39.38M

12.62%27.45M

73.68%29.01M

32.00%21.25M

21.09%18.72M

47.30%24.37M

44.91%16.70M

4.15%16.09M

32.71%15.46M

39.68%16.55M

4.63%11.53M

105.19%15.45M

30.15%11.65M

64.89%11.85M

61.39%11.02M

总资产

-62.02%287.60M

-60.20%312.29M

-45.12%338.02M

28.23%742.78M

66.40%757.16M

61.49%784.56M

66.44%615.89M

77.56%579.27M

27.71%455.02M

26.37%485.82M

20.62%370.02M

29.18%326.25M

57.20%356.31M

63.49%384.44M

20.19%306.78M

9.82%252.55M

-6.90%226.66M

-8.76%235.14M

-5.27%255.25M

66.34%229.96M

总负债

-49.87%25.28M

-52.12%26.66M

-21.30%34.89M

-15.58%39.20M

47.87%50.43M

74.73%55.69M

17.25%44.33M

52.72%46.44M

13.51%34.11M

8.22%31.87M

28.80%37.81M

163.82%30.41M

94.43%30.05M

152.85%29.45M

143.09%29.36M

0.36%11.53M

97.99%15.45M

24.47%11.65M

56.40%12.08M

53.37%11.48M

总权益

-62.88%262.32M

-60.81%285.63M

-46.96%303.13M

32.04%703.58M

67.90%706.73M

60.56%728.87M

72.04%571.55M

80.11%532.84M

29.01%420.92M

27.88%453.95M

19.75%332.21M

22.74%295.84M

54.47%326.26M

58.83%354.98M

14.08%277.42M

10.32%241.03M

-10.37%211.21M

-10.02%223.49M

-7.09%243.17M

67.09%218.48M

现金流量表

经营净额

31.06%-20.42M

-102.19%-3.53M

40.68%-27.29M

110.65%3.25M

25.57%-29.62M

461.69%161.17M

-80.71%-46.01M

10.25%-30.50M

-29.09%-39.80M

-30.16%-44.56M

-18.73%-25.46M

-38.13%-33.98M

-36.49%-30.83M

-2299.09%-34.23M

-9.60%-21.44M

-70.36%-24.60M

-28.08%-22.59M

86.42%-1.43M

-144.84%-19.57M

-33.02%-14.44M

投资净额

78.47%-155.00K

87.08%-73.00K

53.63%-134.00K

65.80%-132.00K

-132.26%-720.00K

40.27%-565.00K

46.58%-289.00K

29.82%-386.00K

0.32%-310.00K

10.92%-946.00K

-54.13%-541.00K

-212.50%-550.00K

45.15%-311.00K

-622.45%-1.06M

-120.75%-351.00K

-21.38%-176.00K

-11.18%-567.00K

30.00%-147.00K

-165.00%-159.00K

-383.33%-145.00K

融资净额

-19600.00%-3.31M

-58000.00%-2.32M

-601.21%-378.63M

-99.91%140.00K

-99.52%17.00K

-100.00%4.00K

9.08%75.54M

54809.86%155.94M

102.93%3.53M

45.62%156.80M

12.76%69.25M

-99.42%284.00K

-82.93%1.74M

91152.54%107.68M

116.13%61.42M

138708.57%48.58M

17780.70%10.19M

180.95%118.00K

-79.72%28.42M

288.89%35.00K

常见问题

Keros Therapeutics Inc的总收入是多少？



根据Keros Therapeutics Inc的FY2025财报，总收入达到了244.06M（同比变化3.55M）。

Keros Therapeutics Inc的流动资产是多少？



根据Keros Therapeutics Inc的FY2025财报，流动资产为315.43M（同比变化-46.44）。

Keros Therapeutics Inc的总资产是多少？



根据Keros Therapeutics Inc的FY2025财报，Keros Therapeutics Inc的总资产为338.02M（同比变化-45.12）。

Keros Therapeutics Inc的总负债是多少？



根据Keros Therapeutics Inc的FY2025财报，Keros Therapeutics Inc的总负债为34.89M（同比变化-21.30）。

Keros Therapeutics Inc的总权益是多少？



根据Keros Therapeutics Inc的FY2025财报，Keros Therapeutics Inc的总权益为303.13M（同比变化-46.96）。

Keros Therapeutics Inc的净营业收入是多少？



根据Keros Therapeutics Inc的FY2025财报，Keros Therapeutics Inc的净营业收入为70.67M（同比变化133.52）。

Keros Therapeutics Inc的净投资是多少？



根据Keros Therapeutics Inc的FY2025财报，Keros Therapeutics Inc的净投资为-1.55M（同比变化19.68）。

Keros Therapeutics Inc的净融资是多少？



根据Keros Therapeutics Inc的FY2025财报，Keros Therapeutics Inc的净融资为-378.47M（同比变化-196.59）。

Keros Therapeutics Inc的每股收益（EPS）是多少？



根据Keros Therapeutics Inc的FY2025财报，每股收益（EPS）为2.34（同比变化146.71）。

Keros Therapeutics Inc的净利润是多少？



根据Keros Therapeutics Inc的FY2025财报，净利润为87.01M（同比变化146.44）。

Keros Therapeutics Inc的净利润率是多少？



根据Keros Therapeutics Inc的FY2025财报，净利润率为35.65（同比变化100.68）。

Keros Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Keros Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为19.90（同比变化147.99）。

Keros Therapeutics Inc的资产回报率（ROA）是多少？



根据Keros Therapeutics Inc的FY2025财报，资产回报率（ROA）为18.24（同比变化148.00）。

Keros Therapeutics Inc的营业利润是多少？



根据Keros Therapeutics Inc的FY2025财报，营业利润为70.67M（同比变化133.52）。